Kimberly Yeatts
Tempus Labs (United States)(US)
Publications by Year
Research Areas
Diabetes Treatment and Management, Extracellular vesicles in disease, Genetic factors in colorectal cancer, Genetic Syndromes and Imprinting, Genetic Associations and Epidemiology
Most-Cited Works
- → Clinical validation of the tempus xT next-generation targeted oncology sequencing assay(2019)228 cited
- → Identification of PVT1 as a Candidate Gene for End-Stage Renal Disease in Type 2 Diabetes Using a Pooling-Based Genome-Wide Single Nucleotide Polymorphism Association Study(2007)200 cited
- → Sequence Variation inPPARGMay Underlie Differential Response to Troglitazone(2005)65 cited
- → Variants in the gene encoding aldose reductase (AKR1B1) and diabetic nephropathy in American Indians(2006)32 cited
- → Programmed death 1 (PD-1) lymphocytes and ligand (PD-L1) in colorectal cancer and their relationship to microsatellite instability status.(2014)18 cited
- → Quantitative Polymerase Chain Reaction Using the Comparative C q Method(2010)5 cited
- → Abstract 4954: Comparison of miR expression patterns in plasma, serum, and cell line cMV(2011)
- → Abstract 4530: A novel blood-based method for evaluating KRAS in circulating microvesicles from colorectal cancer patients(2012)
- Identification of PVT1 as a Candidate Gene for End-Stage Renal Disease in Type 2 Diabetes Using a Pooling-Based Genome-Wide Single Nucleotide Polymorphism(2007)